Latest Tenders From Kazakh

Drafting of The Completion Report

Strengthening Research Opportunities for Nih Grants (Strong): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (Rlis) (Uc2 - Clinical Trial not A...

Interventions to Expand Cancer Screening and Preventive Services to Advance Health in Populations that Experience Health Disparities (R01, Clinical Trial Required)

Drugs with the Active Ingredient Diclofenac (Atc Code: D11ax18 - Topical Dosage Forms Only)

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Metoclopramide (A03fa01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredients Tamsulosin and Dutasteride (G04ca52) as Part of a So-Called Open House Model.

Open House Discount Drug Contracts Fulvestrant, Atc L02ba03

Open House Discount Drug Contracts Tamsulosin and Dutasteride, Atc G04ca52

Medicines with the Active Substance Combination Metoprolol and Hydrochlorothiazide (Atc: C07bb22)

Open Framework Agreement on Drug Discounts in Accordance with § 130A Paragraph 8 Sgb V with the Option to Join at any Time, So-Called Approval Model 2023-04